Brief: Vaxcyte Completes Enrollment Of Opus-1 And Opus-2 Phase 3 Trials Evaluating Vax-31 For The Prevention Of Invasive Pneumococcal Disease And Pneumonia In Adults
23/03/2026 12:36
Vaxcyte Inc PCVX.O: VAXCYTE COMPLETES ENROLLMENT OF OPUS-1 AND OPUS-2 PHASE 3 TRIALS EVALUATING VAX-31 FOR THE PREVENTION OF INVASIVE PNEUMOCOCCAL DISEASE AND PNEUMONIA IN ADULTS VAXCYTE INC - OPUS-3 PHASE 3 RESULTS EXPECTED IN FIRST HALF OF 2027 Source text: ID:nGNX1RfTS1 Further company coverage: PCVX.O